Florida Atlantic University - Business
President & CEO Neuro Pharmalogics Inc.-Orphan Neurology Drug Company
Biotechnology
David D.
Muth
Boca Raton, Florida
Pharmaceutical/Healthcare Executive with extensive track record of increasing shareholder value at Orphan Drug, Large Pharma, Biotech, Medical Device and Specialty Pharmaceutical Companies. Results driven change agent who utilizes a keen strategic focus to build peak performing teams. Background includes hands-on experience in raising capital, licensing/acquisition, strategic planning, managing R&D organization(s), building sales and marketing organizations, domestic and international product development and launches.
Executive Vice President, Chief Commercial Officer & Corporate Development
Catalyst Pharmaceuticals Inc., - a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. Responsibilities included : developing and executed the strategy which transitioned Catalyst from a specialty pharmaceutical into an orphan drug company. Responsible for developing and executing all commercial strategies, building all commercial operations and business development activities.
Adjunct Professor
Adjunct Professor in the Graduate Healthcare Program - Teaching Strategic Planning and Marketing Course
President, Chief Executive Officer and Board Member
Croma, - private global medical device /specialty pharmaceutical company which develops and markets products for the ophthalmology, osteoarthritis and aesthetic dermatology markets. Headquartered in Austria (~ 400 employees) with subsidiaries in Germany, France, Poland, Romania Spain, Canada and the USA. Responsible for North American Operations and Global Business Development. Establish North American operations, gained approval of and launched 10 Ocular Surgical products while building a Canadian Ophthalmology sales organization. In the US managed the filing of 2 IDE’s and negotiated numerous Business Development deals (sold to Valeant Pharmaceuticals)
President
HealthCare Consulting Firm, specializing in:
Strategic Planning and Organizational Transition Management (Domestically and Internationally).
Product Development & Commercialization (Domestically and Internationally).
Corporate & Business Development Transactions.
President & CEO
Bio Pharmaceutical company focused on developing/commercializing innovative therapies for people with rare (orphan) neurological diseases caused by PKG signaling dysfunction including: Hemiplegic Migraine, Neural Trauma (Traumatic Brain Injury(TBI),Spinal shock),Ischemic, Epileptic and other Neurological Conditions.
MBA
Pharmaceutical Marketing (2nd concentration)
BS
Accounting
MBA
Finance